Totipotent Stem Cells represent the most potent and versatile type of stem cell, possessing the unique ability to differentiate into any cell type in the human body, as well as supporting the development of both embryonic and extraembryonic tissues. Totipotent cells can give rise to every cell type required for embryonic development, making them distinct from pluripotent cells, which can differentiate into any cell type but not support the formation of extraembryonic tissues like the placenta. The earliest stages of embryonic development involve totipotent cells, and they are capable of forming an entire organism. Following fertilization, the zygote is totipotent, and as cell division progresses, totipotency is retained in the cells of the morula. However, as the blastocyst forms, cells become pluripotent, with the ability to differentiate into the three germ layers—ectoderm, mesoderm, and endoderm. While totipotent cells are crucial for embryonic development, they are not utilized in most regenerative medicine applications due to ethical and practical considerations, particularly related to the use of embryos. Instead, pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, are more commonly employed for their versatility and ethical feasibility in various research and therapeutic contexts.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States